Rational Use of Antibiotics for Community Acquired Pneumonia in Thi-Qar’s Hospitals
Abstract
Introduction: The hospital and laboratory findings of all adult patients who were hospitalized in Thi-Qar’s hospitals were reviewed during the period (1 November 2020 to 30 August 2021) with a clinical feature of
community acquired pneumonia.
Objective: Evaluation based on differentiation of community acquired pneumonia from other types, location of therapy, treatment strategy, and duration of therapy.
Methodology: We identified potential cases ranging in age from 23 to 75 years at the time of admission. The hospitals findings were requested and reviewed for eligibility. All data were collected by the Case Information Sheet (CIS) project, a general practice research database containing data from hospital patient records of about 42 patients in the Thi-Qar’s hospitals and the details of the database have been described. The Case Information Sheet contains coded and anonymous data on patient demographics, symptom, and treatment including their indications and dosage regimen.
Results: The study revealed that 19% were known to have CAP, the others (81%) had probability to have HCAP. All patients were treated as an inpatient (ward). It was found that 22% of patient should receive either macrolide or doxycycline, but their treatment was different, and 52% should be treated as an inpatient with moderately sever condition.
Conclusion: The study concluded that 40% of patients should be treated as an outpatient, 36% of patients should be treated as either outpatient or inpatient, and 24% of patients should be treated as inpatients. Also, 59% of patients had received over treatment, 24% had received under treatment, and just 9% complied with the guideline therapy. Finally, the duration of therapy was complied with the guideline therapy.
How to cite this article:
Saeed A, Atshan S S, Jabbar L, Alkufi H K. Rational
Use of Antibiotics for Community Acquired
Pneumonia in Thi-Qar’s Hospitals. J Commun
Dis. 2025;57(2):115-121.
DOI: https://doi.org/10.24321/0019.5138.202545
References
Roger walker & Cate Whittlesea. Clinical Pharmacy and Therapeutics. 5th edition. 2012;550.
Godara H. The Washington manual of medical therapeutics. Lippincott Williams & Wilkins; 2013 Jun 10. [Google Scholar]
Brian R. Walker, Nicki R. Colledge, Stuart H. Ralston, Ian D. Penman. Davidson’s Principles and Practice of
Medicine. 22th edition. 2014;682.
Curtis L . Smith. Infectious Diseases, ACCP Updates in Therapeutics, 2018;2-276,277,279.
Copyright (c) 2025 Journal of Communicable Diseases (E-ISSN: 2581-351X & P-ISSN: 0019-5138)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.